Efficacy and safety of different doses and retreatment of rituximab: A randomised, placebo-controlled trial in patients who are biological naïve with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))

Paul Emery, A. Deodhar, W. F. Rigby, J. D. Isaacs, B. Combe, A. J. Racewicz, K. Latinis, C. Abud-Mendoza, L. J. Szczepański, R. A. Roschmann, A. Chen, G. K. Armstrong, W. Douglass, H. Tyrrell

Research output: Contribution to journalArticlepeer-review

266 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of different doses and retreatment of rituximab: A randomised, placebo-controlled trial in patients who are biological naïve with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds